Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors

被引:59
|
作者
Korhonen, LE
Rahnasto, M
Mähönen, NJ
Wittekindt, C
Poso, A
Juvonen, RO
Raunio, H
机构
[1] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
关键词
D O I
10.1021/jm0489713
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to determine the cytochrome P450 1A2 (CYP1A2) inhibition potencies of structurally diverse compounds to create a comprehensive three-dimensional quantitative structure-activity relationship (3D-QSAR) model of CY-P1A2 inhibitors and to use this model to predict the inhibition potencies of an external set of compounds. Fifty-two compounds including naphthalene, lactone and quinoline derivatives were assayed in a 96-well plate format for CY-P1A2 inhibition activity using 7-ethoxyresorufin O-dealkylation as the probe reaction. The IC50 values of the tested compounds varied from 2.3 mu M to over 40 000 mu M. On the basis of this data set, a comparative molecular field analysis (CoMFA) and GRID/GOLPE models were created that yielded novel structural information about the interaction between inhibitory molecules and the CYP1A2 active site. The created CoMFA model was able to accurately predict inhibitory potencies of several structurally unrelated compounds, including selective inhibitors of other cytochrome P450 forms.
引用
收藏
页码:3808 / 3815
页数:8
相关论文
共 50 条
  • [21] In silico analysis of cytochrome P450 1A2 (CYP1A2) inhibitors
    Korhonen, L
    Rahnasto, M
    Mähönen, N
    Poso, A
    Raunio, H
    Juvonen, R
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 285 - 285
  • [22] Effect of the Arg456His mutation on the three-dimensional structure of cytochrome P450 1A2 predicted by molecular dynamics simulations
    Watanabe, Y.
    Kato, K.
    Fukuyoshi, S.
    Hiratsuka, M.
    Yamaotsu, N.
    Hirono, S.
    Gouda, H.
    Oda, A.
    XXIXTH IUPAP CONFERENCE ON COMPUTATIONAL PHYSICS CCP2017, 2018, 1136
  • [23] Three dimensional quantitative structure-activity relationship of cyclooxygenase-2 inhibitors
    Guo, YS
    Chu, FM
    Guo, ZR
    Bai, AP
    ACTA CHIMICA SINICA, 2003, 61 (07) : 1114 - 1120
  • [24] A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1
    Lewis, DFV
    Sams, C
    Loizou, GD
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2003, 17 (01) : 47 - 52
  • [25] Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans
    Tashinga E. Bapiro
    Jane Sayi
    Julia A. Hasler
    Mary Jande
    Gerald Rimoy
    Amos Masselle
    Collen M. Masimirembwa
    European Journal of Clinical Pharmacology, 2005, 61 : 755 - 761
  • [26] Effects of malnutrition on cytochrome P450 1A2 activity in elderly patients
    Hamon-Vilcot, B
    Simon, T
    Becquemont, L
    Poirier, JM
    Piette, F
    Jaillon, P
    THERAPIE, 2004, 59 (02): : 247 - 251
  • [27] Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans
    Bapiro, TE
    Sayi, J
    Hasler, JA
    Jande, M
    Rimoy, G
    Masselle, A
    Masimirembwa, CM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (10) : 755 - 761
  • [28] Three-dimensional Quantitative Structure-activity Relationship Models of HIV-1 Integrase Inhibitors of DKAs
    张美青
    赵文娜
    陆绍永
    结构化学, 2012, 31 (12) : 1769 - 1781
  • [29] Three-dimensional Quantitative Structure-activity Relationship Models of HIV-1 Integrase Inhibitors of DKAs
    Zhang Mei-Qing
    Zhao Wen-Na
    Lu Shao-Yong
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2012, 31 (12) : 1769 - 1781
  • [30] Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2
    Zhou, Shu-Feng
    Yang, Li-Ping
    Wei, Ming Qian
    Duan, Wei
    Chan, Eli
    CURRENT DRUG METABOLISM, 2009, 10 (07) : 713 - 729